Jesús
San Miguel Izquierdo
Consultor Investigador
Nizhny Novgorod State Technical University
Nizhniy Novgorod, RusiaPublicaciones en colaboración con investigadores/as de Nizhny Novgorod State Technical University (2)
2011
-
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. Melphalan-prednisone in the phase III VISTA trial in multiple myeloma
European Journal of Haematology, Vol. 86, Núm. 5, pp. 372-384
2008
-
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
New England Journal of Medicine, Vol. 359, Núm. 9, pp. 906-917